West Pharmaceutical Services, Inc.
NYQ: WSTLive Quote
📈 ZcoreAI Score
Our AI model analyzes West Pharmaceutical Services, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get WST Z-Score →About West Pharmaceutical Services, Inc.
Healthcare
Medical Instruments & Supplies
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
📊 Fundamental Analysis
West Pharmaceutical Services, Inc. demonstrates a healthy profit margin of 16.1%.
The company recently reported 7.5% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 16.9%, which suggests room for improvement in capital utilization.
At a current price of $256.55, WST currently sits at the 49th percentile of its 52-week range (Range: $193.05 - $322.34).
💰 Valuation Insight
WST trades at a 50.9% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
⚠️
Profit Margin
Moderate
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$18.49B
Trailing P/E
37.73
Forward P/E
28.94
Beta (5Y)
1.15
52W High
$322.34
52W Low
$193.05
Avg Volume
1.01M
Day High
Day Low